Nipping HIV in the bud: could we use genotyping to interrupt transmission?
Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation
Protected T-cells persist and proliferate in HIV gene therapy study
Raltegravir has the edge over two protease inhibitors in three-drug comparison study
The 'Boston patients' experience HIV rebound after stem cell transplants
Younger women not at higher risk of HIV from relationships with older men, South African study finds
Self-testing encourages very high uptake of HIV testing in Malawi study
Male life expectancy nine years shorter due to lower male uptake of HIV treatment in rural South Africa
Raltegravir plus boosted darunavir shown to be safe and effective for first-line ART
